Pathology Core
Pathology Core
批准号:
7729379
负责人:
RUSSELL R BROADDUS
金额:
$14.45万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-04 至 2010-08-31
关键词:
AscitesBenignBiopsy SpecimenBloodCancer CenterClinicalCollectionCystDatabasesDiagnosticDoctor of MedicineFormalinFreezingFutureGoalsImmunohistochemistryIn Situ HybridizationIndividualIntranetLiquid substanceMalignant neoplasm of ovaryMicrodissectionNormal tissue morphologyOperative Surgical ProceduresOvarianOvarian DiseasesOvarian TissueOvaryParaffin EmbeddingParaffin TissuePathologistPathologyPatientsProcessPrognostic MarkerReproduction sporesResearch PersonnelResearch Project GrantsResourcesSamplingServicesSlideSourceSpecimenStagingTestingTissue MicroarrayTissuesTumor BankUniversitiesUrinebaseendometriosisexperienceprognosticrepositoryresearch studytumorvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The individual research projects that make up this Ovarian Cancer SPORE application require the
procurement, processing, and analysis of histopathological material from patients with ovarian cancer and
benign ovarian diseases. The research projects have needs for frozen and formalin-fixed, paraffinembedded
samples of tumor and normal tissue. The Pathology Core augments the already established
M.D. Anderson Cancer Center Gynecological Tumor Bank and the P30-sponsored M.D. Anderson Cancer
Center Centralized Tissue Repository with supporting database and intranet access. The Core provides
tissue acquisition by experienced gynecological pathologists to assure high-quality tissues for the
investigators participating in this SPORE as well as investigators of other SPOREs.
The goal of the Pathology Core is to provide frozen tissue, paraffin-embedded tissue, and histopathological
expertise related to the specific needs for the research projects comprising this SPORE proposal. To
achieve this goal, the Pathology Core has the following Specific Aims. Aim 1 is to maintain a frozen and
paraffin-embedded tissue repository of ovarian cancer, benign ovarian processes, and normal ovary. The
primary tissue source is operative and biopsy specimens submitted to the Department of Pathology at M.D.
Anderson Cancer Center. In addition, a subcontract with Duke University provides additional ovarian
tissues, particularly early stage ovarian cancers. Aim 2 is to provide pathological review for all clinical
specimens utilized in the SPORE projects and to provide histopathological technical services as necessary.
Such technical services include immunohistochemistry, in situ hybridization, creation of specific tissue
microarray slides, and microdissection of tissue sections. Aim 3 is to establish a blood/urine/ascites fluid
repository from patients undergoing surgery for ovarian cancer and benign ovarian processes. These fluids
provide the resources for the systemic testing of putative prognostic and diagnostic markers derived from
tissue-based expression array and CGH experiments. Aim 4 is to create and maintain a SPORE Database
for all samples collected at both M.D. Anderson Cancer Center and Duke University. This SPORE Database
is a virtual tissue repository that is electronically shared by all SPORE investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Research Program
-
批准号:10006201
-
项目类别:
-
资助金额:$15.53万
-
财政年份:2019
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Developmental Research Program
-
批准号:9763465
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2019
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Pathology Core
-
批准号:7961953
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2010
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Strategy for the Incorporation of Tissue Biomarkers in the Clinical Management of
-
批准号:7962011
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2010
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Pathology Core
-
批准号:7962038
-
项目类别:
-
资助金额:$9.42万
-
财政年份:2010
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Annual Uterine Cancer Biology Symposium
-
批准号:8007267
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2004
-
负责人:RUSSELL R BROADDUS
-
依托单位:
P2: CTNNB1 Mutation and Wnt Pathway Activation Define Clinically Aggressive Endometrioid Endometrial Carcinoma
-
批准号:10006204
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
MD Anderson Gynecologic SPORE for Uterine Cancers
-
批准号:10006057
-
项目类别:
-
资助金额:$198.64万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
MD Anderson Gynecologic SPORE for Uterine Cancers
-
批准号:10249382
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
P2: CTNNB1 Mutation and Wnt Pathway Activation Define Clinically Aggressive Endometrioid Endometrial Carcinoma
-
批准号:10265741
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
MD Anderson Gynecologic SPORE for Uterine Cancers
-
批准号:9146628
-
项目类别:
-
资助金额:$216.2万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
MD Anderson Gynecologic SPORE for Uterine Cancers
-
批准号:10265734
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Revision: MD Anderson Gynecologic SPORE for Uterine Cancers
-
批准号:9377854
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
MD Anderson Gynecologic SPORE for Uterine Cancers
-
批准号:9763452
-
项目类别:
-
资助金额:$209.02万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Evaluation of siRNA nanoformulations and aerosol delivery for treatment of SARS-CoV-2
-
批准号:10194638
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
P2: CTNNB1 Mutation and Wnt Pathway Activation Define Clinically Aggressive Endometrioid Endometrial Carcinoma
-
批准号:10249389
-
项目类别:
-
资助金额:$21.1万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Pathology Core
-
批准号:10006198
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2003
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Pathology Core
-
批准号:8380492
-
项目类别:
-
资助金额:$12.19万
-
财政年份:--
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Pathology Core
-
批准号:8382328
-
项目类别:
-
资助金额:$9.8万
-
财政年份:--
-
负责人:RUSSELL R BROADDUS
-
依托单位:
Strategy for the Incorporation of Tissue Biomarkers in the Clinical Management of
-
批准号:8521098
-
项目类别:
-
资助金额:$24.84万
-
财政年份:--
-
负责人:RUSSELL R BROADDUS
-
依托单位:
海外基金